[go: up one dir, main page]

WO2009056114A3 - Use of polyethylene glycol powders, and compositions containing the same - Google Patents

Use of polyethylene glycol powders, and compositions containing the same Download PDF

Info

Publication number
WO2009056114A3
WO2009056114A3 PCT/DE2008/001756 DE2008001756W WO2009056114A3 WO 2009056114 A3 WO2009056114 A3 WO 2009056114A3 DE 2008001756 W DE2008001756 W DE 2008001756W WO 2009056114 A3 WO2009056114 A3 WO 2009056114A3
Authority
WO
WIPO (PCT)
Prior art keywords
polyethylene glycol
compositions containing
same
powders
glycol powders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2008/001756
Other languages
German (de)
French (fr)
Other versions
WO2009056114A2 (en
Inventor
Michael Brock
Thorsten Kamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sasol Germany GmbH
Original Assignee
Sasol Germany GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sasol Germany GmbH filed Critical Sasol Germany GmbH
Publication of WO2009056114A2 publication Critical patent/WO2009056114A2/en
Publication of WO2009056114A3 publication Critical patent/WO2009056114A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

The invention relates to the use of polyethylene glycol powders made of spherical polyethylene glycol particles having a narrow particle size distribution as well as compositions containing said powders.
PCT/DE2008/001756 2007-11-02 2008-10-31 Use of polyethylene glycol powders, and compositions containing the same Ceased WO2009056114A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007052870A DE102007052870A1 (en) 2007-11-02 2007-11-02 Use of polyethylene glycol powders and compositions containing them
DE102007052870.3 2007-11-02

Publications (2)

Publication Number Publication Date
WO2009056114A2 WO2009056114A2 (en) 2009-05-07
WO2009056114A3 true WO2009056114A3 (en) 2009-07-09

Family

ID=40445580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001756 Ceased WO2009056114A2 (en) 2007-11-02 2008-10-31 Use of polyethylene glycol powders, and compositions containing the same

Country Status (2)

Country Link
DE (1) DE102007052870A1 (en)
WO (1) WO2009056114A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (en) 2011-03-11 2016-06-01 諾金私人有限公司 Colon cleansing solution, composition for preparing the solution, kit comprising the composition or solution, and method of preparing the same
MY193378A (en) 2012-09-11 2022-10-07 Norgine Bv Compositions comprising peg and ascorbate
DE102015001915B4 (en) * 2015-02-16 2016-12-22 Clariant International Ltd. Use of polyethylene glycol as decoration material, in particular artificial snow
RU2019143354A (en) * 2017-05-30 2021-06-30 Юджин Й. ЧАНЬ FLUOROGENIC PEPTIDE SUBSTRATES FOR MEASURING FACTOR XA IN SOLUTION AND SOLID PHASE

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461546B1 (en) * 1998-08-03 2002-10-08 Ut-Battelle Apparatus for and method of producing monodisperse submicron polymer powders from solution
EP1563973A1 (en) * 2004-02-11 2005-08-17 Clariant GmbH Solid powdered polyethylene glycol having bimodal particle size distribution, its preparation and its use
CN101036668A (en) * 2007-02-15 2007-09-19 刘宇 Grain agent including polyethylene glycol 4000

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0816061B2 (en) * 1988-07-13 1996-02-21 森下ルセル株式会社 Intestinal lavage fluid composition and intestinal lavage fluid
DE19617924A1 (en) 1996-05-05 1997-11-13 Brace Gmbh Chemie Plastics Dat Piezoelectric excitation of sprayed fluid close to nozzle exits
JP4655349B2 (en) * 2000-10-18 2011-03-23 日油株式会社 Polyethylene glycol for oral medicine and method for producing the same
JP5041642B2 (en) * 2001-08-30 2012-10-03 日本製薬株式会社 Composition for oral intestinal lavage and filling preparation for oral intestinal lavage
WO2004089343A1 (en) * 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Water soluble tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461546B1 (en) * 1998-08-03 2002-10-08 Ut-Battelle Apparatus for and method of producing monodisperse submicron polymer powders from solution
EP1563973A1 (en) * 2004-02-11 2005-08-17 Clariant GmbH Solid powdered polyethylene glycol having bimodal particle size distribution, its preparation and its use
CN101036668A (en) * 2007-02-15 2007-09-19 刘宇 Grain agent including polyethylene glycol 4000

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BLATTNER D ET AL: "PERCOLATION THEORY AND COMPACTIBILITY OF BINARY POWDER SYSTEMS", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS, NEW YORK, NY, US, vol. 7, no. 2, 1 February 1990 (1990-02-01), pages 113 - 117, XP008104361, ISSN: 0724-8741, [retrieved on 20041124] *
ROWE R C ET AL: "Polyethylene glycol", HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, LONDON : PHARMACEUTICAL PRESS.; GB, 1 January 2006 (2006-01-01), pages 548 - 549, XP002520824, ISBN: 978-1-58212-058-4 *

Also Published As

Publication number Publication date
DE102007052870A1 (en) 2009-05-07
WO2009056114A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
IL257382B (en) Nucleic acid-lipid particles, compositions comprising the same and uses thereof
WO2012035283A8 (en) Pharmaceutical composition
IL208744A0 (en) Nucleic acid-lipid particles, compositions comprising the same and uses thereof
WO2010084480A3 (en) Delivery particles
WO2010079467A3 (en) Delivery particles
WO2010079466A3 (en) Delivery particles
WO2010079468A3 (en) Delivery particle
WO2012068105A3 (en) Compositions and uses thereof in converting contaminants
WO2011130671A3 (en) Coating compositions for packaging articles and methods of coating
WO2015051054A3 (en) Benefit agent containing delivery particle based on styrene maleic anhydride copolymer
EP1940422A4 (en) Zinc oxide coated particles, compositions containing the same, and methods for making the same
WO2009101593A3 (en) Delivery particle
WO2010014172A3 (en) Delivery particle
WO2007099469A3 (en) Benefit agent containing delivery particle
WO2012024526A3 (en) Conjugates, particles, compositions, and related methods
GEP20156230B (en) Forms of rifaximin and usage thereof
WO2010068471A3 (en) Sensitivity oral care compositions
WO2011060099A3 (en) Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
IL226023A0 (en) Anti-dr5 antibodies, compositions comprising the same and uses thereof
SI2029480T1 (en) Biologicallly active nanoparticles of a carbonate-substituted hydroxyapatite, process for their preparation and compositions incorporating the same
WO2008150537A3 (en) Silica particles and methods of making and using the same
EP2571486A4 (en) Dry powder inhalation composition
EG25372A (en) Device for characterizing the particle size distribution of powders and its uses.
WO2010002613A3 (en) Method of making a dry powder pharmaceutical composition
WO2009039157A3 (en) Orlistat pharmaceutical formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845383

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 08845383

Country of ref document: EP

Kind code of ref document: A2